CPS TECHNOLOGIES CORP/DE/
For the period ended Jun 28, 2025. Filed Aug 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 28, 2025 · Filed Aug 1, 2025
Contents
Item 1. FINANCIAL STATEMENTS (Unaudited)
Balance Sheets (Unaudited)
| June 28, 2025 | December 28, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $2,374,037 | $3,280,687 |
| Marketable securities, at fair value | 1,044,925 | 1,031,001 |
| Accounts receivable-trade | 5,602,703 | 4,858,208 |
| Accounts receivable-other | 416,029 | 177,068 |
| Inventories, net | 5,198,246 | 4,331,066 |
| Prepaid expenses and other current assets | 263,636 | 480,986 |
| Total current assets | 14,899,576 | 14,159,016 |
| Property and equipment: | ||
| Production equipment | 10,659,948 | 10,382,379 |
| Furniture and office equipment | 910,310 | 891,921 |
| Leasehold improvements | 997,830 | 997,830 |
| Total cost | 12,568,088 | 12,272,130 |
| Accumulated depreciation and amortization | (10,698,945) | (10,377,756) |
| Construction in progress | 78,834 | 108,874 |
| Net property and equipment | 1,947,977 | 2,003,248 |
| Intangible assets | 21,363 | - |
| Right-of-use lease asset | 108,000 | 186,000 |
| Deferred taxes, net | 2,392,854 | 2,528,682 |
| Total Assets | $19,369,770 | 18,876,946 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Note payable, current portion | - | 8,130 |
| Accounts payable | 3,286,223 | 3,053,712 |
| Accrued expenses | 1,036,463 | 913,279 |
| Deferred revenue | 30,384 | 172,429 |
| Lease liability, current portion | 108,000 | 160,000 |
| Total current liabilities | 4,461,070 | 4,307,550 |
| Deferred revenue – long term | 31,277 | 31,277 |
| Long term lease liability | - | 26,000 |
| Total liabilities | 4,492,347 | 4,364,827 |
| Commitments & Contingencies | ||
| Stockholders’ equity: | ||
| Common stock, $0.01 par value, authorized 20,000,000 shares; issued 14,661,487 shares; outstanding 14,525,960 shares at each June 28, 2025 and December 28, 2024 | 146,615 | 146,615 |
| Additional paid-in capital | 40,751,927 | 40,580,387 |
| Accumulated other comprehensive income | 9,469 | 15,500 |
| Accumulated deficit | (25,690,450) | (25,890,245) |
| Less cost of 135,527 common shares repurchased at each June 28, 2025 and December 28, 2024 | (340,138) | (340,138) |
| Total stockholders’ equity | 14,877,423 | 14,512,119 |
| Total liabilities and stockholders’ equity | $19,369,770 | $18,876,946 |
Statements of Operations and Other Comprehensive Income (Loss) (Unaudited)
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 28, | June 29, | June 28, | June 29, | |
| 2025 | 2024 | 2025 | 2024 | |
| Product sales | $8,078,657 | $5,030,313 | $15,584,578 | $10,942,947 |
| Cost of product sales | 6,742,341 | 5,260,305 | 13,017,261 | 10,266,629 |
| Gross profit | 1,336,316 | (229,992) | 2,567,317 | 676,318 |
| Selling, general, and administrative expenses | 1,199,389 | 1,084,995 | 2,300,739 | 2,250,917 |
| Income (loss) from operations | 136,927 | (1,314,987) | 266,578 | (1,574,599) |
| Other income, net | 19,025 | 90,851 | 69,501 | 170,021 |
| Net income (loss) before income taxes | 155,952 | (1,224,136) | 336,079 | (1,404,578) |
| Income tax provision (benefit) | 52,119 | (269,832) | 136,284 | (307,120) |
| Net income (loss) | $103,833 | $(954,304) | $199,795 | $(1,097,458) |
| Other comprehensive income | ||||
| Net unrealized gains on available for sale securities | 8,169 | 8,701 | 10,206 | 8,701 |
| Reclassification adjustment for gains included in net income | - | - | (16,237) | - |
| Total other comprehensive income | 8,169 | 8,701 | (6,031) | 8,701 |
| Comprehensive income (loss) | 112,002 | (945,603) | 193,764 | (1,088,757) |
| Net income (loss) per basic common share | $0.01 | $(0.07) | $0.01 | $(0.08) |
| Weighted average number of basic common shares outstanding | 14,525,960 | 14,519,215 | 14,525,960 | 14,519,215 |
| Net income (loss) per diluted common share | $0.01 | $(0.07) | $0.01 | $(0.08) |
| Weighted average number of diluted common shares outstanding | 14,577,433 | 14,519,215 | 14,560,672 | 14,519,215 |
CPS TECHNOLOGIES CORP.
STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 28, 2025 AND JUNE 29, 2024
| Common Stock | |||||||
|---|---|---|---|---|---|---|---|
| Number of shares issued | Par Value | Additional paid-in capital | Accumulated other comprehensive income | Accumulated deficit | Stock repurchased | Total stockholders’ equity | |
| Balance at March 29, 2025 | 14,661,487 | $146,615 | $40,702,574 | $1,300 | $(25,794,283) | $(340,138) | $14,716,068 |
| Share-based compensation expense | - | - | 49,353 | - | - | - | 49,353 |
| Other comprehensive income | - | - | - | 8,169 | - | - | 8,169 |
| Net loss | - | - | - | - | 103,833 | - | 103,833 |
| Balance at June 28, 2025 | 14,661,487 | $146,615 | $40,751,927 | $9,469 | $(25,690,450) | $(340,138) | $14,877,423 |
| Common Stock | |||||||
|---|---|---|---|---|---|---|---|
| Number of shares issued | Par Value | Additional paid-in capital | Accumulated other comprehensive income | Accumulated deficit | Stock repurchased | Total stockholders’ equity | |
| Balance at December 28, 2024 | 14,661,487 | $146,615 | $40,580,387 | $15,500 | $(25,890,245) | $(340,138) | $14,512,119 |
| Share-based compensation expense | - | - | 171,540 | - | - | - | 171,540 |
| Net unrealized gains on available for sale securities | - | - | - | 10,206 | - | - | 10,206 |
| Reclassification adjustment for gains included in net income | - | - | - | (16,237) | - | - | (16,237) |
| Net income | - | - | - | - | 199,795 | - | 199,795 |
| Balance at June 28, 2025 | 14,661,487 | $146,615 | $40,751,927 | $9,469 | $(25,690,450) | $(340,138) | $14,877,423 |
| Common Stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of shares issued · Par Value · Additional paid-in capital · Accumulated other comprehensive income · Accumulated deficit · Stock repurchased · Total stockholders’ equity | ||||||||
| Balance at March 30, 2024 | 14,601,487 | $146,015 | $40,341,855 | $ | - | $(22,897,950) | $(250,138) | $17,339,782 |
| Share-based compensation expense | - | - | 44,480 | - | - | - | 44,480 | |
| Other comprehensive income | - | - | - | 8,701 | - | - | 8,701 | |
| Net loss | - | - | - | - | (954,304) | - | (954,304) | |
| Balance at June 29, 2024 | 14,601,487 | $146,015 | $40,386,335 | $8,701 | $(23,852,254) | $(250,138) | $16,438,659 | |
| Common Stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number of shares issued · Par Value · Additional paid-in capital · Accumulated other comprehensive income · Accumulated deficit · Stock repurchased · Total stockholders’ equity | ||||||||
| Balance at December 30, 2023 | 14,601,487 | $146,015 | $40,180,893 | $ | - | $(22,754,796) | $(250,138) | $17,321,974 |
| Share-based compensation expense | - | - | 205,442 | - | - | - | 205,442 | |
| Other comprehensive income | - | - | - | 8,701 | - | - | 8,701 | |
| Net loss | - | - | - | - | (1,097,458) | - | (1,097,458) | |
| Balance at June 29, 2024 | 14,601,487 | $146,015 | $40,386,335 | $8,701 | $(23,852,254) | $(250,138) | $16,438,659 | |
Statements of Cash Flows (Unaudited)
| Six Months Ended | ||
|---|---|---|
| June 28, | June 29, | |
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $199,795 | $(1,097,458) |
| Adjustments to reconcile net income (loss) to cash used in operating activities: | ||
| Depreciation and amortization | 321,189 | 237,954 |
| Share-based compensation | 171,540 | 205,442 |
| Realized gain on sale of marketable securities | (12,183) | - |
| Deferred taxes | 135,828 | (307,576) |
| Changes in: | ||
| Accounts receivable-trade | (744,495) | 324,862 |
| Accounts receivable-other | (238,961) | (115,157) |
| Inventories | (867,180) | 460,252 |
| Prepaid expenses and other current assets | 217,350 | (90,306) |
| Accounts payable | 232,511 | 52,788 |
| Accrued expenses | 123,184 | (403,284) |
| Deferred revenue | (142,045) | (186,177) |
| Net cash used in operating activities | (603,467) | (918,660) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (265,918) | (815,720) |
| Acquisition cost of patents and trademarks | (21,363) | - |
| Proceeds from sale of marketable securities | 518,000 | - |
| Purchase of marketable securities | (525,772) | (750,000) |
| Net cash used in investing activities | (295,053) | (1,565,720) |
| Cash flows from financing activities: | ||
| Payments on note payable | (8,130) | (23,002) |
| Net cash used in financing activities | (8,130) | (23,002) |
| Net decrease in cash and cash equivalents | (906,650) | (2,507,382) |
| Cash and cash equivalents at beginning of period | 3,280,687 | 8,813,626 |
| Cash and cash equivalents at end of period | $2,374,037 | $6,306,244 |
| Supplemental disclosures of cash flows information: | ||
| Cash paid for interest | 26 | 1,465 |
Notes to Financial Statements
(Unaudited)
(1) Nature of Business
CPS Technologies Corporation (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive, defense and other industries. The Company’s primary advanced material solution is metal-matrix composites ("MMC") which are a combination of metal and ceramic.
CPS also assembles housings and packages for hybrid circuits. These housings and packagesmayinclude components made of metal-matrix composites or theymayinclude components made of more traditional materials such as aluminum.
Using its proprietary MMC technology, the Company also produces light-weight armor, particularly for extreme environments and heavy threat levels.
The Company also engages in research and development, in some cases government funded and in others internally funded, focused on developing new products in response to customer requirements. These products expand our offerings in existing markets and enable penetration into new markets.
(2) Summary of Significant Accounting Policies
As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form10-Q, these notes are condensed and donot contain all disclosures required by generally accepted accounting principles.
The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.
The Company’s balance sheet atDecember 28, 2024has been derived from the audited financial statements at that date, but doesnot include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.
For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form10-K for the year endedDecember 28, 2024and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.cpstechnologysolutions.com.
The results of operations for interim periods arenot necessarily indicative of the results to be expected for the full year.
(3) Marketable Securities
Investments consist of U.S. Treasury Bills with maturities up to one year. Since it is not currently managements intention to hold these debt securities until the maturity dates, these have been classified as available-for-sale (“AFS”) and are recorded on the balance sheet at fair value, with changes in fair value recorded as a component of other comprehensive income.
(4) Fair value ofMarketable Securities
ASC 820,Fair Value Measurements (“ASC 820”) states that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The three-tiered fair value hierarchy, which prioritizes which inputs should be used in measuring fair value, is comprised of: (Level I) observable inputs such as quoted prices in active markets; (Level II) inputs other than quoted prices in active markets that are observable either directly or indirectly and (Level III) unobservable inputs for which there is little or no market data. The fair value hierarchy requires the use of observable market data when available in determining fair value. CPS’ marketable securities consist solely of US Government bonds with a maturity of 12 months or less and which fall under Level II of the fair value hierarchy. The value of these bonds as of June 28, 2025 was $1,044,925 and was $1,031,001 as of December 28, 2024.
| June 28, 2025 | December 28, 2024 | |
|---|---|---|
| Cost basis | $1,033,947 | $1,015,501 |
| Unrealized gain | 10,978 | 15,500 |
| Total fair value | $1,044,925 | $1,031,001 |
(5) Net Income Per Common and Common Equivalent Share
Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share is calculated by dividing net income by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive. Had there been a profit in Q2 and year to date in 2024, the dilutive effect would have been 29,254 shares and 50,607 shares, respectively.
The following table presents the calculation of both basic and diluted EPS:
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 28, | June 29, | June 28, | June 29, | |
| 2025 | 2024 | 2025 | 2024 | |
| Basic EPS Computation: | ||||
| Numerator: | ||||
| Net income (loss) | $103,833 | $(954,304) | $199,795 | $(1,097,458) |
| Denominator: | ||||
| Weighted average | ||||
| Common shares | ||||
| Outstanding | 14,525,960 | 14,519,215 | 14,525,960 | 14,519,215 |
| Basic EPS | $0.01 | $(0.07) | $0.01 | $(0.08) |
| Diluted EPS Computation: | ||||
| Numerator: | ||||
| Net income (loss) | $103,833 | $(954,304) | $199,795 | $(1,097,458) |
| Denominator: | ||||
| Weighted average | ||||
| Common shares | ||||
| Outstanding | 14,525,960 | 14,519,215 | 14,525,960 | 14,519,215 |
| Dilutive effect of stock options | 51,473 | - | 34,712 | - |
| Total Shares | 14,577,433 | 14,519,215 | 14,560,672 | 14,519,215 |
| Diluted EPS | $0.01 | $(0.07) | $0.01 | $(0.08) |
(6) Commitments & Contingencies
Commitments
Operating Leases
The Company hasone real estate lease expiring inFebruary 2026.CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration.None of these equipment leases have been capitalized as the Company elected an accounting policy for short-term leases, which allows lessees to avoid recognizing right-of-use assets and liabilities for leases with terms of12 months or fewer.
The real estate lease expiring in2026 (the “Norton facility lease”) is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized based on the present value of lease payments over the lease term using the Company’s incremental borrowing rate at commencement date. The Company’s lease agreements donot contain any material residual value guarantees or material restrictive covenants.
The Norton facility lease comprises approximately 38 thousand square feet. The lease is triple net lease wherein the Company is responsible for payment of all real estate taxes, operating costs and utilities. The Company also has an option to renew the lease starting inMarch 2026through*February 2032.*The Company is not reasonably certain these extensions will be exercised at this time, and therefore are not included in the lease asset or liability. Annual rental payments range from $160 thousand to $165 thousand through maturity.
The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating lease as ofJune 28, 2025:
| (Dollars in Thousands) | June 28, 2025 |
|---|---|
| Maturity of capitalized lease liabilities | Lease payments |
| 2025 | 83 |
| 2026 | 28 |
| Total undiscounted operating lease payments | $111 |
| Less: Imputed interest | (3) |
| Present value of operating lease liability | $108 |
| Balance Sheet Classification | |
| Current lease liability | $108 |
| Long-term lease liability | - |
| Total operating lease liability | $108 |
| Other Information | |
| Remaining lease term for capitalized operating lease (months) | 8 |
| Discount rate for capitalized operating leases | 6.6% |
Operating Lease Costs and Cash Flows
Operating lease cost and cash paid was $41 thousand during thesecond quarter of2025 and $83 thousand for thesix months ended*June 28, 2025.*These costs are related to its long-term operating lease. All other short-term leases were immaterial.
Finance Leases
The company doesnot have any finance leases.
(7) Share-Based Payments
The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.
During the quarter endedJune 28, 2025,no stock options were granted to employees under the Company’s2020 Equity Incentive Plan Stock Incentive Plan (the “Plan”) andno stock options were granted to outside directors during the quarter endedJune 28, 2025. For the six months ended June 28, 2025 a total of 115,000 stock options and 75,000 stock options were granted to employees and directors, respectively. During the quarter endedJune 29, 2024,no stock options were granted to employees under the Company’s2020 Equity Incentive Plan Stock Incentive Plan (the “Plan”) andno stock options were granted to outside directors during the quarter endedJune 29, 2024. For the six months ended June 29, 2024 a total of 135,500 stock options and 75,000 stock options were granted to employees and directors, respectively
During thethree andsix months endedJune 28, 2025,there wereno options exercised and corresponding shares issued. During thethree andsix months ended*June 29, 2024,*there were no options exercised and corresponding shares issued.
During thethree andsix months endedJune 28, 2025,the Company didnot repurchase any shares for employees to facilitate their exercise of stock options. During thethree andsix months ended*June 29, 2024,*the Company didnot repurchase any shares for employees to facilitate their exercise of stock options.
There were also 1,083,300 options outstanding at a weighted average price of $2.45 with a weighted average remaining term of 7.36 years as of*June 28, 2025,and there were 594,100 options exercisable at a weighted average price of $2.40 with a weighted average remaining term of 6.49 years as ofJune 28, 2025.The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As ofJune 28, 2025,there were 421,400 shares available for future grants under the 2020 Plan and 141,900 shares outstanding under the 2009 Plan. As ofJune 29, 2024,*there were 638,300 shares available for future grants under the 2020 Plan and 236,200 shares outstanding under the 2009 Plan.
As of*June 28, 2025,*there was $559 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 2.41 years.
During thethree andsix months ended*June 28, 2025,*the Company recognized $49,354 and $171,540, respectively, as shared-based compensation expense related to previously granted shares under the Plan.
During thethree andsix months ended*June 29, 2024,*the Company recognized $44,480 and $205,442, respectively, as shared-based compensation expense related to previously granted shares under the Plan.
(8) Inventories
Inventories consist of the following:
| June 28, | December 28, | |
|---|---|---|
| 2025 | 2024 | |
| Raw materials | $2,719,237 | $2,625,305 |
| Work in process | 2,678,705 | 1,880,396 |
| Finished goods | 351,716 | 343,722 |
| Total inventory | 5,749,658 | 4,849,423 |
| Reserve for obsolescence | (551,412) | (518,357) |
| Inventories, net | $5,198,246 | $4,331,066 |
(9) Accrued Expenses
Accrued expenses consist of the following:
| June 28, | December 28, | |
|---|---|---|
| 2025 | 2024 | |
| Accrued legal and accounting | $77,177 | $138,600 |
| Accrued payroll and related expenses | 354,631 | 254,737 |
| Accrued product returns | 500,283 | 429,617 |
| Accrued other | 104,372 | 90,325 |
| $1,036,463 | $913,279 |
(10) Line of Credit
The Company has a $3.0 million revolving line of credit (LOC) with Rockland Trust Company. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of the National Prime Rate as published by the Wall Street Journal (7.5% atJune 28, 2025). On*June 28, 2025,*the Company had $0 of borrowings under this LOC and its borrowing base at the time would have permitted an additional $3.0 million to have been borrowed. The line of credit remains in effect and has been extended to August 5, 2025.
(11) Segment Reporting
The Company views its operations and manages its business asone segment. The Company produces and sells advanced material solutions, primarily metal matrix composites, to assemblers of high density electronics and other specialty components and subassemblies. The Company also assembles housings and packages for hybrid circuits, selling to the same customers mentioned above. These customers represent a single market or segment with similar stringent and well-defined requirements. The Company’s customers, in turn, sell the components and subassemblies which incorporate the products into many different end markets, however, these end markets aretwo tothree levels removed from the Company. The Company also sells armor strike faces to armor manufacturers, using the same manufacturing process used in its other product solutions. The Company makes operating decisions and assesses financial performance only for the Company as a whole and doesnot make operating decisions or assess financial performance by the end markets which ultimately use the products. Our chief operating decision maker (CODM) is Brian Mackey, our President and CEO. The Company's CODM regularly reviews financial information presented and does not evaluate the Company's operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.
The following table presents segment information for the Company's single reporting segment:
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |
| Product sales | $8,078,657 | $5,030,313 | $15,584,578 | $10,942,947 |
| Cost of product sales | 6,742,341 | 5,260,305 | 13,017,261 | 10,266,629 |
| Gross profit (loss) | 1,336,316 | (229,992) | 2,567,317 | 676,318 |
| Selling, general, and administrative expenses | 1,199,389 | 1,084,995 | 2,300,739 | 2,250,917 |
| Income (loss) from operations | 136,927 | (1,314,987) | 266,578 | (1,574,599) |
| Other income, net | 19,025 | 90,851 | 69,501 | 170,021 |
| Income (loss) before income taxes | 155,952 | (1,224,136) | 336,079 | (1,404,578) |
| Income tax provision (benefit) | 52,119 | (269,832 | 136,284 | (307,120) |
| Net income (loss) | $103,833 | $(954,304) | $199,795 | $(1,097,458) |
(12) Income Taxes
A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely thannot" that all or a portion of deferred tax assets willnot be realized. Management has determined that a valuation allowance is not needed as it expects that the deferred tax asset will be fully utilized.
For thethree and six months ended June 28, 2025 the deferred tax asset was decreased $52,119 and $135,828 for the estimated tax provision for Q2 and year to date net income, respectively.
(13) Subsequent Events: Enactment of the One Big Beautiful Bill Act
On July 4, 2025, the President signed into law the One Big Beautiful Bill Act (Public Law 119-21), which includes significant modifications to the Internal Revenue Code. The legislation permanently extends and modifies key provisions of the Tax Cuts and Jobs Act of 2017 and introduces new deductions and credits applicable to both individuals and businesses.
Key provisions relevant to the Company include:
***Restoration of Immediate Expensing for Domestic Research and Experimental ("R&E") Expenditures:***Effective for tax years beginning after December 31, 2024, domestic R&E expenditures may be immediately expensed under new Section 174A, reversing the prior capitalization and amortization requirement. This change may materially impact the Company’s deferred tax assets and current tax expense depending on the volume of qualifying expenditures.
It is anticipated that the unamortized Section 174 R&E expenditures at Q2 2025 will be expensed as follows (subject to further analyses and discussions):
| 2025 | 2026 | Total | Rationale | |
|---|---|---|---|---|
| Q3 2025 | 899,728 | - | 899,728 | Expense remaining unamortized for 2025 and 37.5% of 2022-2024 |
| Q4 2025 | 187,193 | - | 187,193 | Expense 12.5% of 2022-2024 |
| Q1 2026 | - | 187,193 | 187,193 | Expense 12.5% of 2022-2024 |
| Q2 2026 | - | 187,193 | 187,193 | Expense 12.5% of 2022-2024 |
| Q3 2026 | - | 187,193 | 187,193 | Expense 12.5% of 2022-2024 |
| Q4 2026 | - | 187,193 | 187,193 | Expense 12.5% of 2022-2024 |
| Totals | 1,086,921 | 748,772 | 1,835,693 |
***Enhancement of Section 179 Expensing:***The maximum Section 179 deduction is increased to $2.5 million, with a phase-out threshold beginning at $4 million. This expansion is expected to accelerate tax deductions for qualifying property and benefit capital investment strategies.
***Permanent Reinstatement of 100% Bonus Depreciation:***For qualified property acquired and placed in service after January 19, 2025, the Company may elect full expensing under Section 168(k), which is expected to accelerate tax deductions and reduce taxable income in applicable periods.
***Modifications to FDII (now FDDEI):***The deduction under Section 250 for foreign-derived intangible income is reduced to 33.34%, and eligibility criteria are narrowed. These changes may impact export-related tax incentives and deferred tax projections tied to U.S.-held IP.
The Company is currently evaluating the impact of these provisions on its financial statements and tax positions. While the changes are not expected to materially affect prior period results, they may influence future effective tax rates, deferred tax balances, and cash tax obligations. The Company will incorporate these changes into its tax planning and provision calculations for fiscal year 2025 and beyond. However, the full effect of these provisions will depend on the Company's future capital expenditures, R&E activities, financing arrangements, and international operations. The Company will incorporate these changes into its tax provision and planning beginning in fiscal year 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.